SH
Senol, Halil
10 papers · 182 citations · 2023–2026
Publications
10
Citations
182
Years
4
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Morpholine-modified thiosemicarbazones and thiazolidin-4-ones against Alzheimer's key enzymes: From synthesis to inhibition
|
2026 | Article | 11 |
|
Targeting cholinergic dysfunction and neuroinflammation through rationally designed Thieno[3,2-d]pyrimidine hybrids
|
2026 | Article | 0 |
|
Synthesis and biological studies of acetophenone-based novel chalcone, semicarbazone, thiosemicarbazone and indolone derivatives: Structure-Activity relationship, molecular docking, molecular dynamics, and kinetic studies
|
2025 | Article | 27 |
|
New Mannich-type arylidenerhodanines as potent inhibitors of AChE and BChE: synthesis, biological evaluation, cytotoxicity and molecular modeling
|
2025 | Article | 5 |
|
Targeting Lung Cancer: Synthesis, Characterization, Enzyme Inhibition, and Antiproliferative Activity of 1<i>H</i>-Benzo[<i>f</i>]chromen-1-One-Thiosemicarbazones Supported by Molecular Docking
|
2025 | Article | 1 |
|
Quinazolin-4(3<i>H</i>)-One-Based New Glitazones as Dual Inhibitors of α-Glucosidase and Aldose Reductase: Comprehensive Approaches for Managing Diabetes Mellitus and Its Complications
|
2025 | Article | 18 |
|
Development of phenolic Mannich bases as α-glucosidase and aldose reductase inhibitors:<i> In</i><i> vitro</i> and<i> in</i><i> silico</i> approaches for managing diabetes mellitus and its complications
|
2025 | Article | 28 |
|
Design, synthesis, and aldose reductase inhibition assessment of novel Quinazolin-4(3H)-one derivatives with 4-Bromo-2-Fluorobenzene functionality
|
2025 | Article | 22 |
|
Synthesis of pyrrole-heterocyclic derivatives as anti-Alzheimer and antidiabetic candidates: An in vitro-in silico study
|
2024 | Article | 39 |
|
Synthesis of nitrogen-containing oleanolic acid derivatives as carbonic anhydrase and acetylcholinesterase inhibitors
|
2023 | Article | 31 |